Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《新药与临床》 1991-03
Add to Favorite Get Latest Update

Thrombolytic therapy and clinical effects of urokinase

YANG Xue-Yi, HAN Bao-Fu (Shanghai Zhongshan Hospital and Shanghai Institute of Cardiovascular Diseases, Shanghai Medical University, Shanghai 200032)  
Thrombo-embolism diseases were mostly coronary occlusion, cerebrovascu-lar thrombosis and peripheral arterial or venous thrombosis. The main cause of savage and death was thrombolism, the disease incidence is continually rising. Thrombolytic therapy is closely concentrated in clinic. We mainly introduce the mechanism of throm-bolysis by urokinase, clinical utility, therapeutic method, adverse reaction and contraindication. The clinical utility of the throrabolytic agent is evaluated.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved